191
Vaccine Therapy Plus Sargramostim Following Chemotherapy in Treating Patients With Previously Untreated Aggressive Non-Hodgkin’s Lymphoma
Condition(s):LymphomaLast Updated:January 17, 2018Completed
Leukine: 746 Clinical Trials, Page 20 of 75
Hide Studies Not Open or Pending
192
A Neoadjuvant Study of Androgen Ablation Combined With Cyclophosphamide and GVAX Vaccine for Localized Prostate Cancer
Condition(s):Prostate Cancer Adenocarcinoma in SituLast Updated:March 28, 2019Completed
193
Study of Subcutaneous Injection of Low-dose rhGM-CSF +/- WLL in PAP.
Condition(s):Pulmonary Alveolar ProteinosisLast Updated:November 18, 2013Unknown status
194
CHOP-Rituximab Augmented With GM-CSF in Patients With Previously Untreated Diffuse Large B Cell Non-Hodgkin’s Lymphoma
Condition(s):Lymphoma, Non-Hodgkin; Lymphoma, B-Cell; Lymphoma, DiffuseLast Updated:January 18, 2018Terminated
195
Filgrastim Compared With Sargramostim Plus Chemotherapy, Peripheral Stem Cell Transplantation, and Interferon Alfa in Treating Patients With Multiple Myeloma
Condition(s):Multiple Myeloma and Plasma Cell NeoplasmLast Updated:November 29, 2017Terminated
196
Autologous Dendritic Cell-Tumor Cell Immunotherapy for Metastatic Melanoma
Condition(s):Stage IV Melanoma; Stage III MelanomaLast Updated:May 10, 2019Terminated
197
Vaccine Therapy in Treating Patients With Myelodysplastic Syndrome
Condition(s):Leukemia; Myelodysplastic SyndromesLast Updated:January 16, 2013Completed
198
GM-CSF and Rituximab in Treating Patients With Previously Untreated Follicular Non-Hodgkin Lymphoma
Condition(s):LymphomaLast Updated:August 2, 2013Unknown status
199
Sequential/Combination Therapy in Nucleoside or Nucleotide Analogue (NA)-Suppressed Chronic Hepatitis B Patients
Condition(s):Chronic Hepatitis bLast Updated:November 6, 2017Unknown status
200
NK Cells Infusions With Irinotecan, Temozolomide, and Dinutuximab
Condition(s):Relapsed Neuroblastoma; Refractory NeuroblastomaLast Updated:October 28, 2022Recruiting